PriceTargets.com logo

Global Medical REIT - XRN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $40.17
  • Forecasted Upside: 39.35%
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$28.83 As of 11/6/2026 04:59 PM ET
▼ -0.885 (-2.98%)

This chart shows the closing price for XRN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Global Medical REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XRN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XRN

Analyst Price Target is $40.17
▲ +39.35% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Global Medical REIT in the last 3 months. The average price target is $40.17, with a high forecast of $43.00 and a low forecast of $37.00. The average price target represents a 39.35% upside from the last price of $28.83.

This chart shows the closing price for XRN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 9 investment analysts is to hold stock in Global Medical REIT. This rating has held steady since July 2026, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/16/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
8/14/2025
  • 1 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
11/12/2025
  • 1 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/10/2026
  • 1 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/11/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
8/9/2026
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
10/8/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
11/7/2026

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/4/2026HuntingtonInitiated CoverageHold
9/21/2026Cantor FitzgeraldInitiated CoverageOverweight$43.00
9/10/2026HuntingtonInitiated CoverageMarket Perform$37.00
8/13/2026Weiss RatingsUpgradeSell (D+) ➝ Hold (C)
7/30/2026Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
7/22/2026Zacks ResearchUpgradeHold
7/13/2026BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$39.00 ➝ $40.00
7/6/2026Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
6/17/2026Raymond James FinancialInitiated CoverageMarket Perform
5/26/2026Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$40.00 ➝ $42.00
5/18/2026BMO Capital MarketsBoost TargetMarket Perform ➝ Market Perform$33.00 ➝ $39.00
5/11/2026Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
5/7/2026Compass PointDowngradeBuy ➝ Neutral$50.00 ➝ $38.00
4/20/2026Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
1/21/2026Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
12/29/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
12/22/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
12/15/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
12/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
12/1/2025Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
11/25/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/19/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/13/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/11/2025Robert W. BairdLower TargetNeutral ➝ Neutral$45.00 ➝ $41.00
11/7/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
10/13/2025CitigroupUpgradeOutperform
10/13/2025Citizens JmpSet TargetMarket Perform ➝ Market Outperform$40.00
10/13/2025Citizens JmpUpgradeMarket Perform ➝ Outperform$40.00
10/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/24/2025Zacks ResearchUpgradeHold ➝ Strong-Buy
5/8/2025Robert W. BairdLower TargetNeutral ➝ Neutral$50.00 ➝ $45.00
4/3/2025B. Riley FinancialInitiated CoverageNeutral$45.00
4/2/2025B. Riley FinancialUpgradeHold
10/18/2024Berenberg BankInitiated CoverageBuy$58.75
9/19/2024Alliance Global PartnersInitiated CoverageBuy$60.00
5/13/2024B. Riley FinancialLower TargetBuy ➝ Buy$55.00 ➝ $50.00
8/4/2023Compass PointBoost Target$55.00 ➝ $62.50
5/8/2023B. Riley FinancialLower Target$60.00 ➝ $55.00
5/4/2023Stifel NicolausLower Target$65.00 ➝ $55.00
3/6/2023B. Riley FinancialLower TargetBuy$70.00 ➝ $60.00
10/10/2022Robert W. BairdDowngradeOutperform ➝ Neutral
10/6/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform
8/15/2022Compass PointLower Target$85.00
8/9/2022Compass PointLower Target$85.00
7/7/2022Citizens JmpInitiated CoverageMarket Perform
5/10/2022B. Riley FinancialLower Target$90.00 ➝ $80.00
3/2/2022B. Riley FinancialLower Target$100.00 ➝ $90.00
(Data available from 11/7/2021 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/11/2026
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/11/2026
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/10/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/10/2026
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/9/2026
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/8/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/8/2026
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/7/2026

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Global Medical REIT logo
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More

Today's Range

Now: $28.83
Low: $28.70
High: $29.84

50 Day Range

MA: $33.58
Low: $28.72
High: $37.06

52 Week Range

Now: $28.83
Low: $28.09
High: $38.65

Volume

170,281 shs

Average Volume

211,780 shs

Market Capitalization

$381.64 million

P/E Ratio

8.24

Dividend Yield

6.26%

Beta

1.1

Frequently Asked Questions

What sell-side analysts currently cover shares of Global Medical REIT?

The following equities research analysts have issued stock ratings on Global Medical REIT in the last year: BMO Capital Markets, Cantor Fitzgerald, Citizens Jmp, Compass Point, Huntington, Raymond James Financial, Inc., Robert W. Baird, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for XRN.

What is the current price target for Global Medical REIT?

0 Wall Street analysts have set twelve-month price targets for Global Medical REIT in the last year. Their average twelve-month price target is $40.17, suggesting a possible upside of 39.3%. Cantor Fitzgerald has the highest price target set, predicting XRN will reach $43.00 in the next twelve months. Huntington has the lowest price target set, forecasting a price of $37.00 for Global Medical REIT in the next year.
View the latest price targets for XRN.

What is the current consensus analyst rating for Global Medical REIT?

Global Medical REIT currently has 7 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in XRN, but not buy more shares or sell existing shares.
View the latest ratings for XRN.

How do I contact Global Medical REIT's investor relations team?

Global Medical REIT's physical mailing address is 7373 Wisconsin Avenue, Suite 800, Bethesda, MD, 20814. The company's listed phone number is (202) 524-6851 and its investor relations email address is [email protected]. The official website for Global Medical REIT is www.chironre.com. Learn More about contacing Global Medical REIT investor relations.